Download PDF
J Knee Surg 2018; 31(01): 050-055
DOI: 10.1055/s-0037-1600091
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Efficacy of Tranexamic Acid for Hemostasis in Patients Undergoing High Tibial Osteotomy

Dong Won Suh
1   Joint Center, Barunsesang Hospital, Seongnam-si, Gyeonggi-do, Korea
,
Bong Soo Kyung
1   Joint Center, Barunsesang Hospital, Seongnam-si, Gyeonggi-do, Korea
,
Seung-Beom Han
2   Department of Orthopedic Surgery, Anam Hospital, Korea University College of Medicine, Seoul, South Korea
,
Kuhoang Cheong
1   Joint Center, Barunsesang Hospital, Seongnam-si, Gyeonggi-do, Korea
,
Won Hee Lee
1   Joint Center, Barunsesang Hospital, Seongnam-si, Gyeonggi-do, Korea
› Author Affiliations
Further Information

Publication History

20 July 2016

06 February 2017

Publication Date:
29 March 2017 (online)

    Permissions and Reprints

Abstract

Extensive bone bleeding and an uncomfortable hematoma can develop due to the opening gap and space during a medial open high tibial osteotomy (HTO). Tranexamic acid (TXA) has been used in various orthopaedic surgeries to reduce bleeding and wound complications. However, no study has investigated the effect of TXA during HTO. Therefore, the purpose of this study is to evaluate the efficacy of TXA in reducing postoperative blood loss in patients undergoing HTO. The hypothesis is that topical TXA administration will reduce postoperative bleeding in patients undergoing medial opening HTO. Topical TXA (2 g in 20 mL saline) was administered at the osteotomy site in patients (n = 15) who underwent medial open HTO from November 2015 to March 2016. Patients (n = 15) who underwent medial open wedge HTO by the same surgeon from October 2014 to October 2015 were enrolled as a control group for comparison. Drainage volumes on postoperative days (PODs) 1, 2, and 3 as well as hemoglobin (Hb) level on PODs 1, 6, and 13 were measured and compared. Mean total postoperative drainage volume was 246 mL in the TXA group and 377 mL in the control group. Mean drainage volume on POD 1 was 138 mL in the TXA group and 277 mL in the control group (p < 0.05). No differences in drainage volume were detected between the groups on POD 2 or 3. Preoperative Hb levels were 13.0 g/dL in the TXA group and 12.9 g/dL in the control group, which decreased to 11.9 g/dL in the TXA group and 11.2 g/dL in the control group on POD 1. These postoperative Hb differences were significant (p < 0.05). Also, Hb levels were 11.7 and 12.0 g/dL in the TXA group and 11.4 and 11.6 g/dL in the control group on PODs 6 and 13, respectively (p > 0.05). An extensive hematoma requiring additional surgery developed in one case in the control group. No wound complications were detected in the TXA group. Topical TXA was effective for reducing postoperative bleeding after medial open HTO. The level of evidence of the study is Level 3.

Keywords

high tibial osteotomy - hemostasis - tranexamic acid - bleeding

Note

The authors have no financial or personal relationship with other people or organizations that could inappropriately influence this study, including employment, consultancies, stock ownerships, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.


 

  • References

  • 1 Pape D, Dueck K, Haag M, Lorbach O, Seil R, Madry H. Wedge volume and osteotomy surface depend on surgical technique for high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc 2013; 21 (01) 127-133
    CrossrefPubMedGoogle Scholar
  • 2 Brosset T, Pasquier G, Migaud H, Gougeon F. Opening wedge high tibial osteotomy performed without filling the defect but with locking plate fixation (TomoFix™) and early weight-bearing: prospective evaluation of bone union, precision and maintenance of correction in 51 cases. Orthop Traumatol Surg Res 2011; 97 (07) 705-711
    CrossrefPubMedGoogle Scholar
  • 3 Floerkemeier S, Staubli AE, Schroeter S, Goldhahn S, Lobenhoffer P. Outcome after high tibial open-wedge osteotomy: a retrospective evaluation of 533 patients. Knee Surg Sports Traumatol Arthrosc 2013; 21 (01) 170-180
    CrossrefPubMedGoogle Scholar
  • 4 Lobenhoffer P, Agneskirchner J, Zoch W. Open valgus alignment osteotomy of the proximal tibia with fixation by medial plate fixator. Orthopade 2004; 33 (02) 153-160
    CrossrefPubMedGoogle Scholar
  • 5 Martin R, Birmingham TB, Willits K, Litchfield R, Lebel ME, Giffin JR. Adverse event rates and classifications in medial opening wedge high tibial osteotomy. Am J Sports Med 2014; 42 (05) 1118-1126
    CrossrefPubMedGoogle Scholar
  • 6 Schröter S, Gonser CE, Konstantinidis L, Helwig P, Albrecht D. High complication rate after biplanar open wedge high tibial osteotomy stabilized with a new spacer plate (position HTO plate) without bone substitute. Arthroscopy 2011; 27 (05) 644-652
    CrossrefPubMedGoogle Scholar
  • 7 Spahn G. Complications in high tibial (medial opening wedge) osteotomy. Arch Orthop Trauma Surg 2004; 124 (10) 649-653
    CrossrefPubMedGoogle Scholar
  • 8 Elson DW, Petheram TG, Dawson MJ. High reliability in digital planning of medial opening wedge high tibial osteotomy, using Miniaci's method. Knee Surg Sports Traumatol Arthrosc 2015; 23 (07) 2041-2048
    CrossrefPubMedGoogle Scholar
  • 9 Miniaci A, Ballmer FT, Ballmer PM, Jakob RP. Proximal tibial osteotomy. A new fixation device. Clin Orthop Relat Res 1989; (246) 250-259
    PubMedGoogle Scholar
  • 10 Han SB, Lee DH, Shetty GM, Chae DJ, Song JG, Nha KWA. A “safe zone” in medial open-wedge high tibia osteotomy to prevent lateral cortex fracture. Knee Surg Sports Traumatol Arthrosc 2013; 21 (01) 90-95
    CrossrefPubMedGoogle Scholar
  • 11 Alshryda S, Mason J, Sarda P. , et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Joint Surg Am 2013; 95 (21) 1969-1974
    CrossrefPubMedGoogle Scholar
  • 12 Alshryda S, Mason J, Vaghela M. , et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 2013; 95 (21) 1961-1968
    CrossrefPubMedGoogle Scholar
  • 13 Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res 2014; 472 (05) 1552-1557
    CrossrefPubMedGoogle Scholar
  • 14 Chimento GF, Huff T, Ochsner Jr JL, Meyer M, Brandner L, Babin S. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013; 28 (8, Suppl): 74-77
    CrossrefPubMedGoogle Scholar
  • 15 Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013; 28 (8, Suppl): 78-82
    CrossrefPubMedGoogle Scholar
  • 16 Ishida K, Tsumura N, Kitagawa A. , et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011; 35 (11) 1639-1645
    CrossrefPubMedGoogle Scholar
  • 17 Chen S, Wu K, Kong G, Feng W, Deng Z, Wang H. The efficacy of topical tranexamic acid in total hip arthroplasty: a meta-analysis. BMC Musculoskelet Disord 2016; 17: 81
    CrossrefPubMedGoogle Scholar
  • 18 Wu Q, Zhang HA, Liu SL, Meng T, Zhou X, Wang P. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur J Orthop Surg Traumatol 2015; 25 (03) 525-541
    CrossrefPubMedGoogle Scholar
  • 19 Zhao-Yu C, Yan G, Wei C, Yuejv L, Ying-Ze Z. Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature. Knee Surg Sports Traumatol Arthrosc 2014; 22 (12) 3181-3190
    CrossrefPubMedGoogle Scholar
  • 20 Serrano Mateo L, Goudarz Mehdikhani K, Cáceres L, Lee YY, Gonzalez Della Valle A. Topical tranexamic acid may improve early functional outcomes of primary total knee arthroplasty. J Arthroplasty 2016; 31 (07) 1449-1452
    CrossrefPubMedGoogle Scholar
  • 21 Karaaslan F, Karaoğlu S, Yurdakul E. Reducing intra-articular hemarthrosis after arthroscopic anterior cruciate ligament reconstruction by the administration of intravenous tranexamic acid: a prospective, randomized controlled trial. Am J Sports Med 2015; 43 (11) 2720-2726
    CrossrefPubMedGoogle Scholar
  • 22 Xie B, Tian J, Zhou DP. Administration of tranexamic acid reduces postoperative blood loss in calcaneal fractures: a randomized controlled trial. J Foot Ankle Surg 2015; 54 (06) 1106-1110
    CrossrefPubMedGoogle Scholar
  • 23 Bryan AJ, Sanders TL, Trousdale RT, Sierra RJ. Intravenous tranexamic acid decreases allogeneic transfusion requirements in periacetabular osteotomy. Orthopedics 2016; 39 (01) 44-48
    CrossrefPubMedGoogle Scholar
  • 24 Wingerter SA, Keith AD, Schoenecker PL, Baca GR, Clohisy JC. Does tranexamic acid reduce blood loss and transfusion requirements associated with the periacetabular osteotomy?. Clin Orthop Relat Res 2015; 473 (08) 2639-2643
    CrossrefPubMedGoogle Scholar
  • 25 Patel JN, Spanyer JM, Smith LS, Huang J, Yakkanti MR, Malkani AL. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 2014; 29 (08) 1528-1531
    CrossrefPubMedGoogle Scholar
  • 26 Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 2014; 21 (06) 987-993
    CrossrefPubMedGoogle Scholar
  • 27 Wei W, Wei B. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty. J Arthroplasty 2014; 29 (11) 2113-2116
    CrossrefPubMedGoogle Scholar
  • 28 Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 2014; 96 (23) 1937-1944
    CrossrefPubMedGoogle Scholar
  • 29 Hamlin BR, DiGioia AM, Plakseychuk AY, Levison TJ. Topical versus intravenous tranexamic acid in total knee arthroplasty. J Arthroplasty 2015; 30 (03) 384-386
    CrossrefPubMedGoogle Scholar